NDC 13985-549 - ThyroVet
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-549
- Package NDCs from labels
- 13985-549-50, 13985-549-51
- Manufacturer
- MWI/VetOne | Neogen Corporation-Mercer Rd
- Effective date
- 2013-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ThyroVet - MWI/VetOne | Neogen Corporation-Mercer Rd | MWI/VetOne | Neogen Corporation-Mercer Rd | 2013-05-06 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVOTHYROXINE SODIUM | ACTIVE INGREDIENT | 9J765S329G | THYROVET (LEVOTHYROXINE SODIUM) POWDER [MWI/VETONE] | 1 | |
| LEVOTHYROXINE | ACTIVE MOIETY | Q51BO43MG4 | THYROVET (LEVOTHYROXINE SODIUM) POWDER [MWI/VETONE] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 0e0ad9f1-1f52-48ce-a996-79ebe7ad53cd | 2025-06-06 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 247f4d1d-6e65-4f81-a377-4dd88ae16dbb | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70dddaf0-f495-495f-95de-36e9efa2e373 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 91afb351-f067-49a2-bdf0-336ea209718d | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 237cc591-c40b-416f-ac00-96cd61bc59dc | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | faaa1123-7515-46c2-abbb-b0615540c8cf | 2025-05-22 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7f8ec438-8ddf-45d2-be94-ac032e192229 | 2025-05-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | f5fc0f34-744c-4e03-ae9f-e017e4033139 | 2025-04-24 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 65b266af-72a5-4409-ab55-bd14341135aa | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 30ccec8b-3f95-61c7-e063-6394a90a05a0 | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Lupin Pharmaceuticals, Inc. | 18717e58-89fb-4e2f-93b6-d6ac3e988d37 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 2025-03-17 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | f0a63075-631d-43bf-9d8e-df79faf0a278 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 2cf48978-d996-f5ba-e063-6294a90a8824 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 702016f6-8507-471f-b833-3a582aef5d2e | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | RedPharm Drug, Inc | fcb196a2-31a6-437a-e053-6294a90a98ad | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Redpharm drug | fa1bbb6e-ed15-07c9-e053-6294a90aa4a0 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Redpharm drug | fa2aebcd-3cd8-5128-e053-6294a90ac612 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Direct Rx | dd032289-acee-49fc-e053-2a95a90a5999 | 2025-01-22 | Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.